Journal of the National Cancer Institute, ‎0027-8874

Journal

Publications

  1. Published

    Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe

    Raoul Reulen & 20 others, , , , , , , , , , , , , , , , , , , & Michael Hawkins, Feb 2018, In: Journal of the National Cancer Institute. 110, 2

    Research output: Contribution to journalArticlepeer-review

  2. Published

    Risk of soft-tissue sarcoma among 69 460 five-year survivors of childhood cancer in Europe

    Michael Hawkins & 21 others, , , , , , , , , , , , , , , , , , , , Raoul Reulen & , Jun 2018, In: Journal of the National Cancer Institute. 110, 6, p. 649–660

    Research output: Contribution to journalArticlepeer-review

  3. Published

    Sorafenib for older patients with renal cell carcinoma: subset analysis from a randomized trial

    Emilio Porfiri & , 15 Oct 2008, In: Journal of the National Cancer Institute. 100, 20, p. 1454-63 10 p.

    Research output: Contribution to journalArticle

  4. Published
  5. Published

    Speeding up the evaluation of new agents in cancer

    Nicholas James, , , & , 1 Sep 2008, In: Journal of the National Cancer Institute. 100, 17, p. 1204-1214 11 p.

    Research output: Contribution to journalEditorial

  6. Published

    Systematic evaluation of Patient-Reported Outcome protocol content and reporting in cancer trials

    Derek Kyte, Ameeta Retzer, Khaled Ahmed, Tom Keeley, , , , , , , , , , , , , , Grace Turner & Melanie Calvert, Nov 2019, In: Journal of the National Cancer Institute. 111, 11, p. 1170-1178 9 p.

    Research output: Contribution to journalArticlepeer-review

  7. Published

    The effect of metformin vs placebo on sex hormones in Canadian cancer trials group MA.32

    Daniel Rea & 5 others, , , , & , Feb 2021, In: Journal of the National Cancer Institute. 113, 2, p. 192-198 7 p.

    Research output: Contribution to journalArticlepeer-review

  8. Published
Previous 1 2 Next